A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection.
about
First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacyPrimary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tractPrevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gelDifferences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder VirusBeyond 51Cr release: New methods for assessing HIV-1-specific CD8+ T cell responses in peripheral blood and mucosal tissues.Exploring the feasibility of multi-site flow cytometric processing of gut associated lymphoid tissue with centralized data analysis for multi-site clinical trialsLack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection.CCR5/CD4/CXCR4 oligomerization prevents HIV-1 gp120IIIB binding to the cell surfaceHIV Infection and Gut Mucosal Immune Function: Updates on Pathogenesis with Implications for Management and Intervention.The rectal mucosa and condomless receptive anal intercourse in HIV-negative MSM: implications for HIV transmission and preventionCycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels.Biomedical prevention: state of the science.Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells.Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa.Mucosal immunity in human and simian immunodeficiency lentivirus infectionsIsolation and characterization of intestinal epithelial cells from normal and SIV-infected rhesus macaquesR5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitorsRectal microbicide development.HIV infection and the gastrointestinal immune systemCD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis.Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection.R5X4 HIV-1 coreceptor use in primary target cells: implications for coreceptor entry blocking strategies.Selective transmission of R5 HIV-1 variants: where is the gatekeeper?Clinical use of CCR5 inhibitors in HIV and beyondViral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infectionLack of compartmentalization of HIV-1 quasispecies between the gut and peripheral blood compartmentsThe HIV-1-specific protein Casp8p41 induces death of infected cells through Bax/Bak.HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets.Simian immunodeficiency virus infection in neonatal macaques.HIV reservoirs in vivo and new strategies for possible eradication of HIV from the reservoir sites.Breast-feeding and Transmission of HIV-1.Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection.Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals.HIV-1 dynamics in vivo: implications for therapy.Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection.Enhancement of HIV-1 infection and intestinal CD4+ T cell depletion ex vivo by gut microbes altered during chronic HIV-1 infection.Preclinical evaluation of the HIV-1 fusion inhibitor L'644 as a potential candidate microbicideHIV-1 infection of human intestinal lamina propria CD4+ T cells in vitro is enhanced by exposure to commensal Escherichia coli.Saquinavir inhibits early events associated with establishment of HIV-1 infection: potential role for protease inhibitors in prevention.CD4(+) T Follicular Helper and IgA(+) B Cell Numbers in Gut Biopsies from HIV-Infected Subjects on Antiretroviral Therapy Are Similar to HIV-Uninfected Individuals
P2860
Q21135264-C696E50E-328E-47B0-BA57-2292E712BAC6Q22242981-50814537-C579-4184-BAA0-BCD0BCD372A5Q28473376-1C36A5AF-DAEC-4B78-A598-0B0EC13B9722Q28551914-900FF266-9EEB-4B8F-B0DB-2B080A25A016Q30332080-9C47591A-FDEE-44C9-A7DC-D9747417B0AAQ30958546-0819CAED-7171-416F-8A95-F8BB0C82151CQ33265482-DCABBFD7-2A05-4C73-985A-0F5E7C7BBC5DQ33627331-355CD95C-432A-4DFC-A92A-6335C022FC9FQ33651723-A41BE18A-8749-4443-A30B-4E803A2823C5Q33694217-F6977719-7266-467D-919A-D6F9F811C3B2Q33697836-524F6479-3DE2-4F1F-95C8-A06C53E89535Q33765795-0E7919B5-9E48-4F41-9E8F-2B999C1E81BEQ33957148-A9F39126-9F5A-48C0-BCE9-FEC6C198225DQ34039900-60252540-89AB-4253-B35B-FF7CF383F34BQ34131265-BEEECC15-D809-45C2-8A6B-546377141DD9Q34145954-16AB9314-D142-4171-9580-37B2DCA173F8Q34301688-0DD7890B-8241-4860-BB6F-CE4EE8BAFA57Q34575590-03E1378E-9CD3-42EA-94B8-C2F9F0B3696DQ34601874-90430D57-8EC6-4B78-9DF5-7B8CCDC43B70Q34633003-78CCD457-C637-45DC-ACE1-0C77E123EDF3Q34976860-E135B556-FBBA-4B0F-A947-263C86CC476EQ35018129-CFE0E1C3-F05F-46E5-BE47-A728625CEA4DQ35018140-F1B52A81-4FDD-4B46-8239-988DC0CDF14EQ35018145-F92918E4-42E1-4EAC-A734-2B72EF07B230Q35023986-5D57D857-7ABB-4A25-A97B-E04B9FDEF6FEQ35043695-C6B8162B-60D2-4A23-B25C-1FEE43DD13B7Q35140447-9F343D07-716F-4752-8656-4EE10214FE2CQ35156136-42DFCD5A-7A06-46CB-961E-05F181CD1621Q35182139-404ECA0E-BBFE-4810-B703-FA47270A7A4AQ35557244-F1A5391A-DD6B-421F-BACD-1F263EDB9AE2Q35628427-456137BC-81B8-47DE-8FCA-9B7E5244CFD5Q35635026-49C4BBA3-44EC-40B9-945C-BCFBAB3CBB0EQ35640599-0C4DE244-6750-43B1-B781-F36CA3A49AC2Q35701633-76596DC3-91A7-459F-8032-ED5D5320F61BQ35729054-DE0C69E1-CD06-4130-8C18-D85B53357885Q35892944-A8081168-6044-4415-A8BE-0D1227CB4A73Q35941336-41D83341-E6CA-41FF-B1B0-02027FB3DA2BQ36090488-A0E248BB-549E-4A79-BA8C-89F7F707B79EQ36171647-A46E7E5A-2C0F-4EA1-A582-A1893AC44919Q36185114-18D9F530-DADA-4555-889E-B3BC1ACE4059
P2860
A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A preponderance of CCR5(+) CXC ...... ciency virus type 1 infection.
@ast
A preponderance of CCR5(+) CXC ...... ciency virus type 1 infection.
@en
type
label
A preponderance of CCR5(+) CXC ...... ciency virus type 1 infection.
@ast
A preponderance of CCR5(+) CXC ...... ciency virus type 1 infection.
@en
prefLabel
A preponderance of CCR5(+) CXC ...... ciency virus type 1 infection.
@ast
A preponderance of CCR5(+) CXC ...... ciency virus type 1 infection.
@en
P2093
P2860
P1433
P1476
A preponderance of CCR5(+) CXC ...... iciency virus type 1 infection
@en
P2093
P2860
P304
P356
10.1128/JVI.75.18.8390-8399.2001
P577
2001-09-01T00:00:00Z